Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2015

Zhan Y, Kost-Alimova M, Shi X, Leo E, Bardenhagen JP, Shepard HE, et al. Development of novel cellular histone-binding and chromatin-displacement assays for bromodomain drug discovery. Epigenetics Chromatin. 2015;8:37.

Martin NE, Gerke T, Sinnott JA, Stack EC, Andrén O, Andersson S-, et al. Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer. Mol Cancer Res. 2015;13(10):1431-40.

Johnson DP, Spitz GS, Tharkar S, Quayle SN, Shearstone JR, Jones S, et al. HDAC1,2 inhibition impairs EZH2- and BBAP-mediated DNA repair to overcome chemoresistance in EZH2 gain-of-function mutant diffuse large B-cell lymphoma. Oncotarget. 2015;6(7):4863-87.

Bellmunt J, Werner L, Bamias A, Fay AP, Park RS, Riester M, et al. HER2 as a target in invasive urothelial carcinoma. Cancer Med. 2015;4(6):844-52.

Linares JF, Duran A, Reina-Campos M, Aza-Blanc P, Campos A, Moscat J, et al. Amino Acid Activation of mTORC1 by a PB1-Domain-Driven Kinase Complex Cascade. Cell Rep. 2015;12(8):1339-52.

Rider JR, Fiorentino M, Kelly R, Gerke T, Jordahl K, Sinnott JA, et al. Tumor expression of adiponectin receptor 2 and lethal prostate cancer. Carcinogenesis. 2015;36(6):639-47.

Weidner A-, Molina D, DeSimone RA, Cohen MA, Giorgadze T, Scognamiglio T, et al. Riedel thyroiditis: Fine needle aspiration findings of a rare entity. Diagn Cytopathol. 2015;43(9):747-50.

Zhao X, Chen-Kiang S, Shetty S, Di Liberto M, Bodo J, Durkin L, et al. CCMCL1: a new model of aggressive mantle cell lymphoma. Blood. 2015;125(17):2730-2.

Mitchell CJ, Getnet D, Kim M-, Manda SS, Kumar P, Huang T-, et al. A multi-omic analysis of human naïve CD4+ T cells. BMC Syst Biol. 2015;9:75.

Scognamiglio T, Joshi R, Kuhel WI, Tabbara SO, M Rezaei K, Hoda RS. Noninvasive carcinoma ex pleomorphic adenoma of the parotid gland: A difficult diagnosis on fine needle aspiration. Cytojournal. 2015;12:7.